Quayle; Steven Norman

Patent Applications and Registrations

Patent applications and USPTO patent grants for Quayle; Steven Norman.The latest application filed is for "increasing expression of interferon regulated genes with combinatons of histone deacetylase inhibitors and immunomodulatory drugs".

Company Profile

2.5.11

Quayle; Steven Norman - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Increasing Expression Of Interferon Regulated Genes With Combinatons Of Histone Deacetylase Inhibitors And Immunomodulatory Drugs App 20220288066 - Quayle; Steven Norman ; et al.	2022-09-15
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof Grant 11,337,975 - Quayle , et al. May 24, 2	2022-05-24
Methods of use and pharmaceutical combinations of histone deacetylase inhibitors and CD20 inhibitory antibodies Grant 11,324,744 - Jones , et al. May 10, 2	2022-05-10
Increasing expression of interferon regulated genes with combinations of histone deacetylase inhibitors and immunomodulatory drugs Grant 11,311,540 - Quayle , et al. April 26, 2	2022-04-26
Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors Grant 11,298,354 - Wong , et al. April 12, 2	2022-04-12
Combinations Of Histone Deacetylase Inhibitors And Immunomodulatory Drugs App 20200323849 - Quayle; Steven Norman ; et al.	2020-10-15
Increasing Expression Of Interferon Regulated Genes With Combinatons Of Histone Deacetylase Inhibitors And Immunomodulatory Drugs App 20190046529 - Quayle; Steven Norman ; et al.	2019-02-14
Combinations of histone deacetylase inhibitors and immunomodulatory drugs Grant 9,949,972 - Quayle , et al. April 24, 2	2018-04-24
Methods Of Use And Pharmaceutical Combinations Of Histone Deacetylase Inhibitors And Cd20 Inhibitory Antibodies App 20180036306 - Jones; Simon Steward ; et al.	2018-02-08
Combinations Of Histone Deacetylase Inhibitors And Immunomodulatory Drugs App 20150150871 - Quayle; Steven Norman ; et al.	2015-06-04
Hdac Inhibitors, Alone Or In Combination With Btk Inhibitors, For Treating Nonhodgkin's Lymphoma App 20150105409 - Quayle; Steven Norman ; et al.	2015-04-16
Combinations Of Histone Deacetylase Inhibitors And Immunomodulatory Drugs App 20150105358 - Quayle; Steven Norman ; et al.	2015-04-16
HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's Lymphoma App 20150105383 - Quayle; Steven Norman ; et al.	2015-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.